Načítá se...
A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease
Susceptibility to multiple autoimmune diseases is associated with common gene polymorphisms influencing IL-2 signaling and T(reg) function, making T(reg)-specific expansion by IL-2 a compelling therapeutic approach to treatment. As an in vivo IL-2 half-life enhancer we used a non-targeted, effector-...
Uloženo v:
| Vydáno v: | J Autoimmun |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Academic Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6284106/ https://ncbi.nlm.nih.gov/pubmed/30446251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaut.2018.10.017 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|